Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Artículo Open Access |
| Veröffentlicht: |
Wiley
2024
|
| Schlagworte: | |
| Online-Zugang: | https://onlinelibrary.wiley.com/doi/10.1111/1753-0407.13541 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| _version_ | 1867003692584009728 |
|---|---|
| author | Joanna Helena Sliwowska Nicola Elizabeth Woods Abdullah Rzgallah Alzahrani Elpiniki Paspali Rothwelle Joseph Tate Valerie Anne Ferro |
| author_facet | Joanna Helena Sliwowska Nicola Elizabeth Woods Abdullah Rzgallah Alzahrani Elpiniki Paspali Rothwelle Joseph Tate Valerie Anne Ferro Joanna Helena Sliwowska Nicola Elizabeth Woods Abdullah Rzgallah Alzahrani Elpiniki Paspali Rothwelle Joseph Tate Valerie Anne Ferro |
| collection | Wiley Open Access |
| contents | Kisspeptin a potential therapeutic target in treatment of both metabolic and reproductive dysfunction Joanna Helena Sliwowska Nicola Elizabeth Woods Abdullah Rzgallah Alzahrani Elpiniki Paspali Rothwelle Joseph Tate Valerie Anne Ferro Journal of Diabetes AbstractKisspeptins (KPs) are proteins that were first recognized to have antimetastatic action. Later, the critical role of this peptide in the regulation of reproduction was proved. In recent years, evidence has been accumulated supporting a role for KPs in regulating metabolic processes in a sexual dimorphic manner. It has been proposed that KPs regulate metabolism both indirectly via gonadal hormones and/or directly via the kisspeptin receptor in the brain, brown adipose tissue, and pancreas. The aim of the review is to provide both experimental and clinical evidence indicating that KPs are peptides linking metabolism and reproduction. We propose that KPs could be used as a potential target to treat both metabolic and reproductive abnormalities. Thus, we focus on the consequences of disruptions in KPs and their receptors in metabolic conditions such as diabetes, undernutrition, obesity, and reproductive disorders (hypogonadotropic hypogonadism and polycystic ovary syndrome). Data from both animal models and human subjects indicate that alterations in KPs in the case of metabolic imbalance lead also to disruptions in reproductive functions. Changes both in the hypothalamic and peripheral KP systems in animal models of the aforementioned disorders are discussed. Finally, an overview of current clinical studies involving KP in fertility and metabolism show fewer studies on metabolism (15%) and only one to date on both. Presented data indicate a dynamic and emerging field of KP studies as possible therapeutic targets in treatments of both reproductive and metabolic dysfunctions.image 10.1111/1753-0407.13541 http://creativecommons.org/licenses/by/4.0/ |
| doi_str_mv | 10.1111/1753-0407.13541 |
| format | Artículo Open Access |
| id | wiley_oa_10_1111_1753_0407_13541 |
| institution | Wiley Open Access |
| license_str_mv | http://creativecommons.org/licenses/by/4.0/ |
| publishDate | 2024 |
| publisher | Wiley |
| record_format | wiley_oa |
| spellingShingle | Kisspeptin a potential therapeutic target in treatment of both metabolic and reproductive dysfunction Joanna Helena Sliwowska Nicola Elizabeth Woods Abdullah Rzgallah Alzahrani Elpiniki Paspali Rothwelle Joseph Tate Valerie Anne Ferro Journal of Diabetes Kisspeptin a potential therapeutic target in treatment of both metabolic and reproductive dysfunction Joanna Helena Sliwowska Nicola Elizabeth Woods Abdullah Rzgallah Alzahrani Elpiniki Paspali Rothwelle Joseph Tate Valerie Anne Ferro Journal of Diabetes AbstractKisspeptins (KPs) are proteins that were first recognized to have antimetastatic action. Later, the critical role of this peptide in the regulation of reproduction was proved. In recent years, evidence has been accumulated supporting a role for KPs in regulating metabolic processes in a sexual dimorphic manner. It has been proposed that KPs regulate metabolism both indirectly via gonadal hormones and/or directly via the kisspeptin receptor in the brain, brown adipose tissue, and pancreas. The aim of the review is to provide both experimental and clinical evidence indicating that KPs are peptides linking metabolism and reproduction. We propose that KPs could be used as a potential target to treat both metabolic and reproductive abnormalities. Thus, we focus on the consequences of disruptions in KPs and their receptors in metabolic conditions such as diabetes, undernutrition, obesity, and reproductive disorders (hypogonadotropic hypogonadism and polycystic ovary syndrome). Data from both animal models and human subjects indicate that alterations in KPs in the case of metabolic imbalance lead also to disruptions in reproductive functions. Changes both in the hypothalamic and peripheral KP systems in animal models of the aforementioned disorders are discussed. Finally, an overview of current clinical studies involving KP in fertility and metabolism show fewer studies on metabolism (15%) and only one to date on both. Presented data indicate a dynamic and emerging field of KP studies as possible therapeutic targets in treatments of both reproductive and metabolic dysfunctions.image 10.1111/1753-0407.13541 http://creativecommons.org/licenses/by/4.0/ |
| title | Kisspeptin a potential therapeutic target in treatment of both metabolic and reproductive dysfunction |
| topic | Journal of Diabetes |
| url | https://onlinelibrary.wiley.com/doi/10.1111/1753-0407.13541 |